Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response

Staphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel S. aureus vaccine (SA4Ag) is in development, targeting the capsular polysaccharides (CPs) and two virulence-associated surface proteins. Vaccine-elicited antibody responses to CPs are efficacious agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupont, Christopher D., Scully, Ingrid L., Zimnisky, Ross M., Monian, Brinda, Rossitto, Christina P., O'Connell, Ellen B., Jansen, Kathrin U., Anderson, Annaliesa S., Love, J. Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106056/
https://www.ncbi.nlm.nih.gov/pubmed/30135219
http://dx.doi.org/10.1128/mSphere.00217-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106056/
https://www.ncbi.nlm.nih.gov/pubmed/30135219
http://dx.doi.org/10.1128/mSphere.00217-18

Ejemplares similares